Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of interest in everyday activities, appetite changes, sleep disturbances and, in ...

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

A recent study published in Nature Mental Health suggests that using biological and behavioral markers can help predict how ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar depression. Clinical trials showed significant symptom improvement and potential ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults. This approval marks ...

Major Depressive Disorder (MDD) is a leading cause of global disability, and pharmacological intervention remains a cornerstone of its management. First-line agents typically comprise selective ...

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved ...

Add Yahoo as a preferred source to see more of our stories on Google. Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has ...

Blaming yourself for having depression can make life with the condition much harder. Here’s what to do instead to help ...

Major Depressive Disorder (MDD) is a prevalent, disabling condition characterised by persistent low mood, anhedonia and cognitive disturbances. Neuroimaging modalities such as functional magnetic ...

Military families with TRICARE can now access FDA-cleared TMS depression treatment at Brain Treatment Center locations ...